Cellebrite Announces Fourth Quarter 2022 Results
ARR of $249 million, up 33% year-over-year Fourth-quarter revenue of $74.0 million, Increase 9% year-over-year Fourth-quarter adjusted EBITDA of $16.1 million, 21.8% adjusted EBITDA margin PETAH TIKVA, Israel and TYSONS